David M. Goldberg

Professor Goldberg received the degrees of B.Sc. (Hons. Biochem.) in 1958, MBChB in 1959, Ph.D. in 1965 and MD (thesis) in 1974, all from the University of Glasgow. Further postgraduate qualifications include Fellowships of the Royal Society of Chemistry (1972), the Royal College of Pathologists (1978), and the Royal College of Physicians of Canada (1987). From 1967-75 he held the post of Consultant in Chemical Pathology at the Royal Hospital Sheffield (once occupied by Sir Hans Krebs) and Lecturer at the University of Sheffield; from 1975-87 he was Biochemist-in-Chief at the Hospital for Sick Children, Toronto, and Professor in the Department of Clinical Biochemistry at the University of Toronto from 1975 to the present, serving as Chair of that Department from 1977-87. He was instrumental in forming the International Society of Enzymology, serving initially as Board Member, then Vice-President (1977-83), and is currently President. His editorial responsibilities include Editor of Clinical Biochemistry (1982-94), membership of many Editorial Boards including Clinical Chemistry and Clinica Chimica Acta, and he is currently Joint Editor-in-Chief of Critical Reviews in Clinical Laboratory Sciences and Associate Editor of the European Journal of Laboratory Medicine. His research over a 38-year period has focused upon the enzymology of cancer, diseases of the liver and pancreas, adipocyte differentiation and lipid metabolism, but is now devoted to the role of alcohol and plant polyphenols in preventing atherosclerosis and coronary heart disease.

Avrum I. Gotlieb

Professor Gotlieb, MD, CM, FRCPC, is Chair of the Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, a staff pathologist at The Toronto Hospital and Director of the Vascular Research Laboratory at The Toronto Hospital Research Institute. Dr. Gotlieb carries out research on atherosclerosis and vascular and heart valve diseases. His focus is on understanding the mechanisms involved in the repair of injuries to blood vessels, especially as it relates to endothelium, smooth muscle cells, and interstitial heart valve cells. The objective is to utilize the basic science to develop clinical strategies that enhance repair processes to both prevent and to effectively treat cardiovascular diseases. Dr. Gotlieb has been twice awarded the prestigious WT Aikins Teaching Award from the Faculty of Medicine, University of Toronto. Dr. Gotlieb is President of the Society of Cardiovascular Pathology, a member of the Council of the American Society of Investigative Pathology and Chair of its Program Committee and is an Associate Editor of the American Journal of Pathology.

Eleftherios P. Diamandis

Professor Diamandis, MD, PhD, FRCPC, is currently Head, Section of Clinical Biochemistry, Department of Pathology and Laboratory Medicine, Mount Sinai Hospital and Head, Division of Clinical Biochemistry, Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto. Dr. Diamandis has published over 200 original papers and his current research interests include pathogenesis of breast, prostate and other hormone-dependent cancers and development of new immunological and molecular techniques for diagnosis, monitoring and prognosis of cancer.

George Steiner

Dr. George Steiner is an internationally recognized expert in the field of diabetes and atherosclerosis. His research has primarily focussed on those atherogenic factors that involve lipoprotein metabolism in diabetes and insulin resistance. Last summer, he was awarded the Banting and Best Memorial Lectureship of the International Diabetes Federation. He directs the multinational Diabetes Atherosclerosis Intervention Study, the first study specifically designed to examine whether correcting the dyslipoproteinemias of diabetes will reduce the risk of coronary atherosclerosis in that disease. Currently he is Professor of Medicine and Physiology, and he heads the World Health Organization Collaborating Centre for the Study of Atherosclerosis in Diabetes, both at the University of Toronto.

Charles H. Hollenberg

A native of Winnipeg, Dr. Hollenberg completed undergraduate science and medical degrees at the University of Manitoba, followed by postgraduate training in Montreal and Boston, becoming in 1959 a Fellow of the Royal College of Physicians and Surgeons of Canada. In 1960 he became the Markle Scholar in Medical Science and joined the Faculty of Medicine at McGill University and the medical staff at Montreal General Hospital. In 1970 he became Sir John and Lady Eaton Professor of Medicine, University of Toronto and Physician-in-Chief, Toronto General Hospital. In 1981 he became the Charles H. Best Professor of Medical Research at the University of Toronto. In 1983 he became Vice Provost of Health Sciences at the University of Toronto. In 1989 he became Director of the Banting and Best Diabetes Centre and, in 1991 President of the Ontario Cancer Treatment & Research Foundation. In June 1997 he assumed his present position as President and Chief Executive Officer of Cancer Care Ontario. During this illustrious career Dr. Hollenberg received numerous awards and several honorary degrees, including Fellow of the Royal Society of Canada and Officer of the Order of Canada.

Version 1.1(2), revised April 22, 1998